Spectrum Pharmaceuticals, Inc. (SPPI) to Present Corporate Update at the Deutsche Bank (DB) 38th Annual Health Care Conference in Boston on May 30th
5/23/2013 7:49:04 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) to Present Corporate Update at the UBS Global Healthcare Conference in New York City on May 20th
5/13/2013 7:15:18 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) to Present Corporate Update at the Bank of America (BAC) Merrill Lynch 2013 Health Care Conference in Las Vegas on May 14th
5/10/2013 8:02:15 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Reports Financial Results for First Quarter 2013
5/9/2013 7:45:38 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Announces First Quarter 2013 Financial Results Teleconference and Webcast
5/2/2013 8:16:22 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Initiates Phase 2 Study of Long-Acting GCSF Drug Candidate, SPI-2012, for the Treatment of Chemotherapy-Induced Neutropenia
4/8/2013 10:02:07 AM
More...
|
Hagens Berman Notifies Spectrum Pharmaceuticals, Inc. (SPPI) Investors of Pending Class-Action Lawsuit and May 13, 2013, Lead Plaintiff Deadline
3/22/2013 9:35:02 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) to Present Corporate Update at the 25th Annual ROTH Conference in Laguna Niguel on March 20th
3/15/2013 6:27:38 AM
More...
|
Ligand Pharmaceuticals Inc. (LGND) Lifts '13 Outlook; Signs a License Deal With Spectrum Pharmaceuticals, Inc. (SPPI)
3/14/2013 7:26:19 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Provides Corporate Update
3/13/2013 9:06:49 AM
More...
|
|